23:29 , Oct 3, 2018 |  BC Innovations  |  Distillery Therapeutics

Infectious disease

INDICATION: Chagas disease Cell cultures and mouse studies identified multiple 7-deazaadenosine analogs that could help treat Chagas disease. Chemical synthesis and testing in human lung fibroblast cell-based assays of 7-deazaadenosine analogs yielded four compounds that...
00:38 , Jan 6, 2018 |  BioCentury  |  Finance

Burgeoning bellwethers

  The miserable performance of large cap biotechs last quarter is likely to be a boon for small- and mid-cap players this year, in more ways than one. Buysiders spent most of 2017 focusing to...
18:04 , Sep 1, 2017 |  BC Week In Review  |  Clinical News

FDA approves Chemo's Chagas treatment

FDA granted accelerated approval to benznidazole from the Chemo Research S.L. unit of Chemo Group (Barcelona, Spain) to treat Chagas disease caused by...
00:04 , Aug 30, 2017 |  BC Extra  |  Company News

FDA approves first Chagas treatment

FDA granted accelerated approval to benznidazole from the Chemo Research S.L. unit of Chemo Group (Madrid, Spain) to treat Chagas disease in children ages two to 12 years. FDA said the oral small molecule antiprotozoal...
07:00 , Apr 17, 2014 |  BC Innovations  |  Translation in Brief

Translational tidbits

AstraZeneca plc had a busy March, announcing five new public-private partnerships and the launch of its Open Innovation website to list additional partnership opportunities ( see "Selected public-private partnerships for March 2014"). One of the...
07:00 , Mar 24, 2014 |  BC Week In Review  |  Company News

Japan BCG, Astellas, Dainippon Sumitomo, Eisai, Merck KGaA, Aeras, Drugs for Neglected Diseases initiative (DNDi), Liverpool School of Tropical Medicine (LSTM),

The Global Health Innovative Technology (GHIT) awarded $12.5 million as part of the second round of awards to four partnerships developing drugs and vaccines to treat schistosomiasis, Chagas disease, parasitic roundworms and tuberculosis. The awards...